Day: December 5, 2019

Oslo, 5 DecemberInteroil notifies that the following correction has been made to the Q3 Financial Report 2019. Equity for the consolidated group  as of September 30, 2019 has been corrected upwards by USD 2.350 million to USD -6.116 million and the Trade and other payables account has been corrected downwards in the same amount.This correction reflects the issuance of a total of 7,354,554 shares in connection with conversion of debt and further compensation to the sellers of the Argentinian assets, as announced last July 19. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentInteroil Q3 2019 Report (corrected)

Resolutions adopted at the Annual General Meeting 2019                     Today, 5 December 2019, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted:The annual report for the financial year 2018/19 was adopted. Distribution of year-end dividend of DKK 12.00 per share of nominally DKK 1.00 was approved. In addition to the interim dividend of DKK 5.00 per share of nominally DKK 1.00 paid out in connection with Coloplast A/S’ half-year results, this brings the total dividend paid for the year to DKK 17.00 per share of nominally DKK 1.00. The remuneration report for the financial year 2018/19 was approved. The following proposals from the Board of Directors were adopted: The remuneration of the members of the Board of Directors for the financial year 2019/20. Updated remuneration policy complying...

Beslutninger vedtaget på den ordinære generalforsamling 2019Årsrapporten for regnskabsåret 2018/19 blev godkendt. Forslag om udbetaling af ordinært udbytte på 12,00 kr. pr. aktie á 1,00 kr. blev godkendt. I tillæg til de 5,00 kr. pr. aktie á 1,00 kr. udbetalt ved halvåret, vil der således være udbetalt udbytte på samlet 17,00 kr. pr. aktie á 1,00 kr. for året. Vederlagsrapporten for regnskabsåret 2018/19 blev godkendt. De følgende forslag fra bestyrelsen blev vedtaget: Godkendelse af bestyrelsens vederlag for regnskabsåret 2019/20. Opdateret vederlagspolitik udarbejdet i overensstemmelse med de nye krav i selskabslovens §§ 139 og 139a. Ændring af § 8 i Coloplast A/S’ vedtægter – Dagsorden. To nye dagsordenspunkter er inkluderet: (i) fremlæggelse og godkendelse af vederlagsrapport og (ii) godkendelse af bestyrelsens vederlag for indeværende...

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced data from the Company’s Phase 1b/2 clinical trial of its non-covalent BTK inhibitor vecabrutinib in adults with relapsed/refractory chronic lymphocytic leukemia (CLL) and other B-cell malignancies. The results will be presented on Sunday, December 8, from 6:00-8:00 p.m. ET in a poster session titled “CLL: Therapy, excluding Transplantation: Poster II” at the 60th American Society of Hematology (ASH) Annual Meeting in Orlando, Florida. The poster, titled “Ongoing Results of  a Phase 1b/2 Dose Escalation and Cohort-Expansion Study of the Selective, Noncovalent, Reversible Bruton’s Tyrosine Kinase Inhibitor, Vecabrutinib, in B-Cell Malignancies,” Abstract No. 3041, will be available at www.sunesis.com on Sunday.The...

TORONTO, 05 déc. 2019 (GLOBE NEWSWIRE) — La Société de Gestion AGF Limitée a déclaré un actif géré global donnant droit à des honoraires de 38,8 milliards de dollars pour le mois terminé le 30 novembre 2019.                      

SCOTTSDALE, Ariz., Dec. 05, 2019 (GLOBE NEWSWIRE) — AgJunction Inc. (TSX: AJX) (“AgJunction” or the “Company”), the Autosteering Company™, today announced that it has appointed Lori Ell, the Chair of the Company’s Board of Directors, as Interim President and Chief Executive Officer of the Company, following the departure of David E. Vaughn as President and Chief Executive Officer.“Dave has accomplished much at AgJunction having knitted together a diverse group of companies, monetized non-core assets and rationalized operations in our new Scottsdale head office,” said Ms. Ell. “More importantly, he has recruited a very strong leadership team who I look forward to working with through this transition. On behalf of the entire Board of Directors, I would like to thank Dave for his years of service...

Sýn hf. hefur sagt upp samningi sínum við Íslandsbanka hf. um viðskiptavakt og tekur uppsögnin gildi 19.desember 2019. Sýn hf. mun áfram vera með samning við Landsbankann hf. um viðskiptavakt.

LiiteOVARO_5.12_trades